Related Experiment Video
Updated: Apr 20, 2026

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
Genetic screening and testing in an episode-based payment model: preserving patient autonomy
Sharon Sutherland1, Ruth M Farrell, Charles Lockwood
1Department of Obstetrics and Gynecology, Cleveland Clinic, and the Departments of Obstetrics and Gynecology and Bioethics, Genomic Medicine Institute, Cleveland Clinic, Cleveland, and the College of Medicine, The Ohio State University, Columbus, Ohio.
Ohio
Area of Science:
- Healthcare Economics
- Maternal Health
- Medical Ethics
Background:
- Ohio is implementing an episode-based payment model for perinatal care.
- This model assigns all costs of care for a live birth to the delivering provider.
- Reimbursement will be tiered, with rewards or penalties based on cost and quality.
Purpose of the Study:
- To analyze the implications of Ohio's new episode-based payment model for perinatal care.
- To examine the potential conflict between physician financial incentives and patient autonomy in prenatal genetic testing.
- To assess the impact of this model on access to and utilization of prenatal diagnostic services.
Main Methods:
- Analysis of the proposed episode-based payment structure for perinatal services in Ohio.
- Review of current practices and guidelines for prenatal genetic screening and diagnostic testing.
- Ethical analysis of the impact on informed consent and patient decision-making.
Main Results:
- The model includes all costs of genetic screening and diagnostic testing in the episode calculation.
- This creates a potential conflict between physician financial incentives and the principle of patient autonomy.
- Physicians may face penalties for providing genetic testing, potentially limiting patient access.
Conclusions:
- The proposed payment model may create barriers to essential prenatal genetic services.
- Patient autonomy and informed decision-making regarding genetic testing could be compromised.
- A re-evaluation of the reimbursement structure is needed to align financial incentives with high-quality, patient-centered perinatal care.
More Related Videos
Related Concept Videos
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Pharmacogenetics and Pharmacogenomics: Overview
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Preventive Healthcare Services
Pharmacogenomics: Identification of New Drug Targets

